Patient preferences for stratified medicine in psoriasis: a discrete choice experiment*

Garima Dalal; Stuart Wright; Caroline Vass; Niall Davison; Geert Vander Stichele; Catherine Smith; Christopher Em Griffiths; Katherine Payne

doi:10.1111/bjd.20482

Abstract

1 min read

This study indicates that individuals with psoriasis would value a biologic calculator and suggested that such a biologic calculator should have sufficient accuracy to predict future response and risk of serious infection from the biologic.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2019

Risk prediction model for serious infections in psoriasis

Zenas Z N Yiu, Christina Sorbe, Mark Lunt, Stephan Jeff Rustenbach, L Kühl, Matthias Augustin, K.J. Mason, Darren M. Ashcroft, Christopher Em Griffiths, Richard B. Warren

Article2019

A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis

Zenas Z N Yiu, K.J. Mason, Juliet N. Barker, Philip Hampton, Kathleen McElhone, Catherine Smith, Richard B. Warren, Christopher Em Griffiths, Mark Lunt, A. David Burden

Letter2010

Management of psoriasis in pregnancy: time to deliver?

Christopher Em Griffiths

Article2006

Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with U.K. dermatologists

Darren M. Ashcroft, Seston Em, Christopher Em Griffiths

Article2019

Infliximab and risk of serious infection in patients with psoriasis

Zenas Z N Yiu, Darren M. Ashcroft, Ian Evans, Kathleen McElhone, Mark Lunt, Catherine Smith, Shernaz Walton, Ruth Murphy, NJ Reynolds, A.D. Ormerod, Christopher Em Griffiths, Richard B. Warren